Study the Antibacterial Mechanism of Diclofenac and its Activity Alone or Combined with Ciprofloxacin in Treating Urinary Tract Infection
DOI:
https://doi.org/10.31185/wjps.191Keywords:
Diclofenac; urinary tract infection; antibacterial activity, human pathogens.Abstract
This study aimed to compare the effects of diclofenac, ciprofloxacin and their combination groups on urine tract infection (U.T.I.s) caused by resistance E coli 0157 H7 in vitro and in vivo. Two hundred urine samples were collected from adult women patients suffering from U.T.I.s from February 2022 to July 2022. The urine specimen was cultured on the blood agar and then incubated at 37°C for (1-2) days; MacConkey agar is the media used for determining the biochemistry results, and identification by Rapidchek test which was performed on typical colonies from the selective plate. The M.I.C effect of Diclofenac began at (25600µg/ml) against resistance E coli 0157H7 while M.I.C of ciprofloxacin it was at (0.96mg/ml), but M.I.C of a combination between (diclofenacn+ciprofloxacin) it was at (400+0.48) mg/ml. Resistance induction assay,with the ciprofloxacin has increased four times, while with the diclofenac has doubled, whilst the combination between (diclofenacn+ciprofloxacin) has no changed after 21 days, according to M.I.C.in the time-kill assay, it was proved that the ciprofloxacin and the combination between (diclofenacn+ciprofloxacin) works after 6 hours, compared to the diclofenac, which started to reduce bacterial counting after 40. After that, the examination was carried out by scanning electronic microscope (S.E.M.) to exam the mechanics of diclofenac,work which was found that it was works as anti-biofilm In this study, forty-eighth (48) rabbits were used and divided into six groups as follow positive control (P.C.), negative control (N.C.), diclofenac (D.C.) in 1mg/kg group, ciprofloxacin (C.I.P.)in7mg/kg group, combination (ciprofloxacin 3.5 mg/kg+diclofenac1mg/kg)COM1 group and combination (ciprofloxacin 1.75 mg/kg+diclofenac1mg/kg) com2 All animals (injected with 0.1 ml in CFU E coli 0157 H7 by urinary catheterization route excepting negative control all group excepting negative control resulted in a significant increase in pus cell, epithelium cell concentration in the urine after three days E coli 0157 H7 infection comparison with negative control while in all experimental period after (14 days) showed no significant (P < 0.05) between positive control (P.C.) and diclofenac treated groups but combination COM1 group and com2 decrease significantly (P< 0.05) after (seven and fourteen) days comparison with positive control. diclofenac can be combined with antibiotics as an anti-virulence agent, enhancing the immune system's ability to eradicate infection
References
Abbas A, Atallah H, El-Sayed A, El-Ganiny M(2020). Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus. Arch. Microbiol., 202(1):2751–2760. https:// doi:10.1007/s00203-020-01992-y.
Abidi S, Ahmed K, Kazmi S (2019). The antibiofilm activity ofAcetylsalicylic acid, Mefenamic acid, acetaminophen against biofilms formedby P. aeruginosa and S. epidermidis. J. Pak. Med. Assoc., 1(2): 1493–1495.
Activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus. J. Glob. Antimicrob. Resist., 10: 70–74.
Akoachere JF, Yvonne S, Akum NH, Seraphine EN(2012) Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns. BMC Res Notes., 5:219–219.
Al-Dawmy A, Yousif A (2013). Prevalence of E. coli O157:H7 in intestinal and Urinary tract infection in children. Intern. J Adv. Res.,1(8): 111-120.
AL-Dujaily A, Mahmood, A (2022). Evaluation of Antibacterial and Antibiofilm Activity of Biogenic Silver Nanoparticles and Gentamicin Against Staphylococcus aureus Isolated from Caprine Mastitis. The Iraqi Journal of Veterinary Medicine, 46(1):10–16. https://doi.org/10.30539/ijvm.v46i1.1309.
Al-Iraqi O, Shareef Y, Dhahir H (2017). Urinary tract bacterial infection of local Iraqi buffaloes (Bubalus Bubalis) in Mosul city. The Iraqi Journal of Veterinary Medicine, 40(2):124–130. https://doi.org/10.30539/iraqijvm.v40i2.123.
Al-Rudha, A (2016). Distribution of E.coli O157:H7 in fecal and urine samples of cattle: E.coli O157:H7, Cattle, Fecal, Urine. The Iraqi Journal of Veterinary Medicine, 40(1): 79–82. https://doi.org/10.30539/iraqijvm.v40i1.142.
Al-Taii D, Yousif, A (2022). Effects of E.coli O157:H7 Experimental Infections on Rabbits. The Iraqi Journal of Veterinary Medicine, 43(1): 34–42. https://doi.org/10.30539/iraqijvm.v43i1.468.
Al-Zubaidy R, Shukr M, Ahmed M (2018). Contamination of the local produced broilers carcasses with Escherichia coli O157:H7 and its effect in public health in Diyala province. The Iraqi Journal of Veterinary Medicine, 41(2): 113–117. https://doi.org/10.30539/iraqijvm.v41i2.59.
antibacterial drug target. Eur J Clin Microbiol Infect Dis., 28(8): 881–91.
Bartlett J, Auwaerter P, Pham P (2010). The Johns Hopkins ABX Guide. Diagnosis and Treatment of Infectious Diseases. 2010 2nd Edition. Jones & Bartlett Publishers, Sudbury MA. (ISBN: 978-0-7637-8108-8).
(BAM)- Bacteriological Analytical Manuel (2001). Center for Food Safety & Applied Nutrition, Food & Drug Administration. U.S. p.1- 946.
Belfield K, Bayston R,Hajduk N Levell G, Birchal l P, and Daniel M (2017). Evaluation of combinations of putative anti-biofilm agents and antibioticsto eradicate biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J. Antimicrob. Chemother., 72: 2531–2538. doi: 10.1093/jac/dkx192
ChanWL, Yee ZY,Raja I, Yap KY (2017). Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial
CLSI Performance Standards for Antimicrobial Susceptibility Testing(2020). 30th ed.; CLSI Supplement M100; Clinical and Laboratory Standards Institute: Wayne, PA, USA.
Collee J, Fraser A, Marminon P, Simmon A, Machie and Mecarteny (1996) . Paractical Medical Microbiology . 14thed Charchill Livingstone New York.
De la Salle B, Meijer P, Thomas A, Simundic AM(2017). Special issue on External Quality Assessment in Laboratory Medicine – current challenges and future trends Biochem Med (Zagreb)., 27:19-22. https://doi.org/10.11613/BM.2017.003
Gould V, Umscheid A, Agarwal K, Kuntz G, Pegues A(2009). Healthcare Infection Control Practices Advisory Committee. Infection Control and Hospital Epidemiology, 31(1): 319-326. http://dx.doi.org/10.1086/651091.
Guerini N, Arthur M, Shackelford D, Koohmaraie M (2006).Evaluation of Escherichia coli O157:H7 growth media for use in test-and-hold procedures for ground beef processing. J Food Prot., 5(1) :1007-1011.
Kahlous A,Bawarish M, Sarhan A,Küpper M, Hasaba A, Rajab M(2017). Using Chemoinformatics, Bioinformatics, and Bioassay to Predict and Explain the Antibacterial Activity of Nonantibiotic Food and Drug Administration Drugs. Assay DrugDev. Technol., 15(3): 89–105. https:// doi:10.1089/adt.2016.771
Kapoor J, Saigal S, Elongavan A (2017). Action and resistance mechanisms of antibiotics: A guide for clinicians. Journal of Anaesthesiology Clinical Pharmacology , 33 (3): 300-305. https:// doi: 10.4103/joacp.JOACP_349_15
Khudhir Z (2022). Evaluation the Antibacterial Activity of the Brine, Nisin Solution, and Ozonated Water Against E. coli O157:H7 in the Experimentally Local Produced Soft Cheese. The Iraqi Journal of Veterinary Medicine, 45(1): 17–21. https://doi.org/10.30539/ijvm.v45i1.1035.
Laudy E, Mrówka A, Krajewska J, Tyski S(2016). The influence of efflux pump inhibitors on the activity of non-antibiotic NSAIDS against gram-negative rods. PLoS ONE., 11(1): e0147131.
Leão C, Borges A, Simões M (2020). NSAIDs as a drug repurposing strategy for biofilm control. Antibiotics, 9(591): https:// doi: 10.3390/antibiotics9090591
Malema S, Abia K, Tandlich R, Zuma B, Kahinda M, Ubomba-Jaswa E (2018). Antibiotic-Resistant Pathogenic Escherichia coli Isolated from Rooftop Rainwater-Harvesting Tanks in the Eastern Cape, South Africa. Int J Environ Res. Public Health., 15(892): 1-14. https://doi.org/10.3390/ijerph15050892.
Mazumdar K, Dastidar SG, Park JH, Dutta NK(2009). The anti-inflammatory non-antibiotic helper compound diclofenac: an
Mundt LA, Shanahan K, Graff’s (2011).Textbook of Urinalysis and Body Fluids. 2nd ed. United States of America: Wolters Kluwer/Lippincott Williams & Wilkins.
Muvunyi CM, Masaisa F, Bayingana C, Mutesa L, Musemakweri A, Muhirwa G(2011). Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines. Am J Trop Med Hyg., 84:923–928.
Najim N, Mustafa F (2017). The combined effect of bacteriocin-producing Lactobacillus rhamnosus GG-ATCC and Lactoperoxidase system activation on microbiological quality of raw milk with special emphasis against E.coli O157:H7 in milk. The Iraqi Journal of Veterinary Medicine, 40(2): 66–72. https://doi.org/10.30539/iraqijvm.v40i2.114.
Paes Leme RC, da Silva RB (2021). Antimicrobial Activity of Non-steroidal Anti-inflammatory Drugs on Biofilm: Current Evidence and Potential for Drug Repurposing. Front. Microbiol., 12:707629.
PereiraS G, Domingues V S, Theriága J, Chasqueira J M, and Paixão P (2018). Non-antimicrobial drugs: etodolac as a possible antimicrobial or Adjuvant Agent Against ESKAPE Pathogens. The Open Microbiology, 12(1):288-296 DOI:10.2174/1874285801812010288
Rainsford KD(2007). Anti-inflammatory drugs in the 21st century. Subcell. Biochem., 42: 3–27.
Salem-Milani A, Esrafil G, Saeed R(2013). Antibacterial Effect of Diclofenac Sodium on Enterococcus faecalis. J Dent (Tehran)., 10(1) : 16–27.
Taneike I, Zhang H, Wakisaka-Saito N, Yamamoto T (2002). Enterohemolysin operon of Shiga toxin-producing Escherichia coli: a virulence function of inflammatory cytokine production from human monocytes. FEBS Letters, 524(3):219-224. https://doi.org/10.1016/S0014-5793(02)03027-2.
Verma T, Bhaskarla C, Sadhir I, Sreedharan S, Nandi D (2018). Nonsteroidal anti-inflammatory drugs, Acetaminophen and Ibuprofen, induce phenotypic antibiotic resistance in Escherichia coli: roles of marA and acrB. FEMS Microbiology Letters, 365( 22): https://doi.org/10.1093/femsle/fny251
